Literature DB >> 2967305

Divergent correlations of circulating dehydroepiandrosterone sulfate and testosterone with insulin levels and insulin receptor binding.

E D Schriock1, C K Buffington, G D Hubert, B R Kurtz, A E Kitabchi, J E Buster, J R Givens.   

Abstract

We evaluated the insulin response to a standard oral glucose tolerance test (OGTT) and in vitro insulin binding to erythrocytes (RBC) in 26 women from 3 groups: Group NW, normal women (n = 11); Group DS, women (n = 9) with elevated serum DHEAS concentrations, greater than 400 micrograms/dl (greater than 10.84 mumol/L); and Group IR, women (n = 6) with elevated basal plasma insulin concentrations (IRI). There was a significant linear correlation between the area under the insulin response curve (IRI-AUC) and serum testosterone (T) (r = 0.78, p = 0.0001). Using stepwise multiple linear regression, IRI-AUC was characterized as a function of both serum T and DHEAS; positively with T and negatively with DHEAS. In vitro (n = 17), there was a positive correlation between RBC-insulin binding and serum DHEAS (r = 0.54, p = 0.029) and a negative correlation between RBC-binding and T (r = -0.57, p = 0.017). We conclude that DHEAS may enhance insulin binding and action and that DHEAS and T have divergent functional relationships with IRI. DHEAS and T may therefore exert opposing effects on insulin secretion and action.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2967305     DOI: 10.1210/jcem-66-6-1329

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  15 in total

1.  Dehydroepiandrosterone sulfate levels in women. Relationships with age, body mass index and insulin levels.

Authors:  E Mazza; M Maccario; J Ramunni; C Gauna; A Bertagna; A M Barberis; S Patroncini; M Messina; E Ghigo
Journal:  J Endocrinol Invest       Date:  1999-10       Impact factor: 4.256

2.  The relationships between testosterone, body composition, and insulin resistance: a lesson from a case of extreme hyperandrogenism.

Authors:  Elena Volpi; Steven A Lieberman; Dennis M Ferrer; Charles R Gilkison; Blake B Rasmussen; Manubai Nagamani; Randall J Urban
Journal:  Diabetes Care       Date:  2005-02       Impact factor: 19.112

3.  Dehydroepiandrosterone protects against oxidative stress-induced endothelial dysfunction in ovariectomized rats.

Authors:  João Paulo Gabriel Camporez; Eliana Hiromi Akamine; Ana Paula Davel; Celso Rodrigues Franci; Luciana Venturini Rossoni; Carla Roberta de Oliveira Carvalho
Journal:  J Physiol       Date:  2011-03-14       Impact factor: 5.182

4.  Prostate cancer risk: the significance of differences in age related changes in serum conjugated and unconjugated steroid hormone concentrations between Arab and Caucasian men.

Authors:  E O Kehinde; A O Akanji; A Memon; A A Bashir; A S Daar; K A Al-Awadi; T Fatinikun
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

Review 5.  Dehydroepiandrosterone and diseases of aging.

Authors:  R R Watson; A Huls; M Araghinikuam; S Chung
Journal:  Drugs Aging       Date:  1996-10       Impact factor: 3.923

Review 6.  Nutrition, hormones, and breast cancer: is insulin the missing link?

Authors:  R Kaaks
Journal:  Cancer Causes Control       Date:  1996-11       Impact factor: 2.506

7.  Hyperinsulinemia in polycystic ovary syndrome: relationship to clinical and hormonal factors.

Authors:  A Vidal-Puig; M Muñoz-Torres; E Jodar-Gimeno; C García-Calvente; P Lardelli; M E Ruiz-Requena; F Escobar-Jiménez
Journal:  Clin Investig       Date:  1994-11

8.  Sex-specific action of insulin to acutely increase the metabolic clearance rate of dehydroepiandrosterone in humans.

Authors:  J E Nestler; Z Kahwash
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

9.  Altered adrenal and thyroid function in children with insulin-dependent diabetes mellitus.

Authors:  G Radetti; C Paganini; L Gentili; F Barbin; B Pasquino; M Zachmann
Journal:  Acta Diabetol       Date:  1994-09       Impact factor: 4.280

10.  Dehydroepiandrosterone stimulates phosphorylation of FoxO1 in vascular endothelial cells via phosphatidylinositol 3-kinase- and protein kinase A-dependent signaling pathways to regulate ET-1 synthesis and secretion.

Authors:  Hui Chen; Alice Seraphina Lin; Yunhua Li; Chad E N Reiter; Maria R Ver; Michael J Quon
Journal:  J Biol Chem       Date:  2008-08-21       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.